Brad Otto is a General Partner at SpringTide Ventures since May 2021, with additional roles as a Board Observer at OpenLoop and Nest Health, and as a Board Member at Helm Health and Paloma Health. Starting in October 2023, Brad serves as a Board Observer for WearLinq and an Investor in Leash Bio and Aegle Health Partners. Brad has also been involved as an Investor in Debut and Sami since 2022. Educationally, Brad holds an MBA from Harvard University and has further credentials from the UMN Carlson School of Management.
This person is not in the org chart
This person is not in any teams
This person is not in any offices